Memphasys Ltd Market Cap ($8.74 Million)
Market Cap & Net Worth: Memphasys Ltd (MEM)
Memphasys Ltd market cap. Memphasys Ltd (AU:MEM) has a market capitalization of $8.74 Million (AU$12.35 Million) as of November 8, 2026. Listed on the AU stock exchange, this Australia-based company holds position #27266 globally and #1302 in its home market, demonstrating a -20.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Memphasys Ltd's stock price AU$0.00 by its total outstanding shares 3087233743 (3.09 Billion). Also see Memphasys Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Memphasys Ltd Market Cap History (2015–2026)
Memphasys Ltd market cap history from 2015 to 2026. Data shows change from $808.01 Million to $8.74 Million (-33.18% CAGR). Check MEM share price today for real-time trading data and today's change.
Memphasys Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Memphasys Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Memphasys Ltd annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
29.02x
Memphasys Ltd's market cap is 29.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $107.47 Million | $63.96K | -$2.17 Million | 1680.32x | N/A |
| 2021 | $203.15 Million | $211.48K | -$1.49 Million | 960.60x | N/A |
| 2022 | $30.58 Million | $27.15K | -$2.08 Million | 1126.48x | N/A |
| 2023 | $26.21 Million | $15.37K | -$3.40 Million | 1705.35x | N/A |
| 2024 | $17.48 Million | $60.00K | -$4.44 Million | 291.26x | N/A |
| 2025 | $15.29 Million | $526.92K | -$4.94 Million | 29.02x | N/A |
Competitor Companies of MEM by Market Capitalization
Companies near Memphasys Ltd in the global market cap rankings as of November 8, 2026. Also see balance sheet size of Memphasys Ltd for a full breakdown of the balance sheet.
Key companies related to Memphasys Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Memphasys Ltd (2015–2026)
Market capitalization of Memphasys Ltd from 2015 to today. Between 2015 and today, Memphasys Ltd's market cap moved from $808.01 Million to $ 8.74 Million, with a yearly change of -33.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$8.74 Million | -42.86% |
| 2025 | AU$15.29 Million | -12.50% |
| 2024 | AU$17.48 Million | -33.33% |
| 2023 | AU$26.21 Million | -14.29% |
| 2022 | AU$30.58 Million | -84.95% |
| 2021 | AU$203.15 Million | -7.00% |
| 2020 | AU$218.44 Million | +100.00% |
| 2019 | AU$109.22 Million | +81.16% |
| 2018 | AU$60.29 Million | -6.44% |
| 2017 | AU$64.44 Million | -40.04% |
| 2016 | AU$107.47 Million | -86.70% |
| 2015 | AU$808.01 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Memphasys Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.74 Million USD |
| MoneyControl | $8.74 Million USD |
| MarketWatch | $8.74 Million USD |
| marketcap.company | $8.74 Million USD |
| Reuters | $8.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Memphasys Ltd
Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port… Read more